先声药业递交注射用曲拉西利新药上市申请 系首个骨髓保护CDK4/6抑制剂

七印授权

603Y6X0WEMRO5Z7UGDQSYFYJIOTZ55499QLBHAL4Z13W85Y0OG

2021-12-13 05:22:22

article

879055B50CDAEB710726410359A5DEE1807A709F0BE1792BDE34F144C289E628

zh-CN

7ECAEAACF51738AEB7C8867D8E1CEADECD0D2F4E

10882750

02636d79fc7c7cc37b9cb348037eec28743d030e5d570d0d69837a3587bed31880

c5251ff5b42337ed39a7be5079abb51d436933b681bc4c87e306f140c8298e79751f377ad51673bbb583b44bd5dee9b9b4a8011e8f6af0ec312487b08b6003071c

{"parameters":{"adaptation":"n","price":"100000"},"type":"cm"}

yuanben_61b6d88ee58bf8.93190843

原本认证

https://www.yuanben.io/article/48392118-dfab-40dd-a1bc-5f6d534b0b20

{"author":"每日经济新闻","authorization_pub_key":"03040cbbeae1adf91c3efd7306d09c6005403a041f9b7405dac489d4f8126fef8c"}